KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Costar (CSGP) Research & Development (2016 - 2026)

Costar has reported Research & Development over the past 17 years, most recently at $114.0 million for Q1 2026.

  • Quarterly Research & Development rose 20.0% to $114.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $425.5 million through Mar 2026, up 25.66% year-over-year, with the annual reading at $406.0 million for FY2025, 24.54% up from the prior year.
  • Research & Development was $114.0 million for Q1 2026 at Costar, up from $109.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $114.0 million in Q1 2026 and troughed at $51.6 million in Q2 2022.
  • The 5-year median for Research & Development is $79.6 million (2024), against an average of $78.6 million.
  • Year-over-year, Research & Development rose 6.21% in 2022 and then skyrocketed 31.33% in 2025.
  • A 5-year view of Research & Development shows it stood at $58.4 million in 2022, then rose by 20.25% to $70.2 million in 2023, then grew by 18.23% to $83.0 million in 2024, then surged by 31.33% to $109.0 million in 2025, then increased by 4.59% to $114.0 million in 2026.
  • Per Business Quant, the three most recent readings for CSGP's Research & Development are $114.0 million (Q1 2026), $109.0 million (Q4 2025), and $105.4 million (Q3 2025).